Boston Scientific Recalls Venous Stent System Due Device Migration
Boston Scientific has recalled the VICI SDS and VICI RDS Venous Stent Systems due to the potential for stent migration from the location of original implantation. The stent systems are used to treat obstructions and occlusions in narrowed or blocked venous veins.
The Class I recall involves 31,798 devices in the United States; the products were distributed between September 21, 2018 and April 9, 2021. Thus far there have been 17 complaints and reported injuries related to the device problem. No deaths have been reported.
On April 12, Boston Scientific sent an Urgent Medical Device Recall Notification to customers requesting they immediately discontinue device use and to remove affected units from inventory.
Related Articles
-
“M.I.Tech is an innovator in nonvascular stent development, with product offerings that complement our existing stent portfolio.”
-
“We are pleased to expand our board of directors with two highly qualified executives from different sectors of the healthcare industry.”
-
The UK MHRA has published “Software and Artificial Intelligence as a Medical Device.” The guidance document assembles previous guidances and regulatory requirements for SaMD and AIaMD devices seeking commercialization in the UK market.
-
“Addressing unmet needs across pediatric populations is critical to advancing children’s health, and we are delighted to once again work with pioneering companies that seek to bridge this care gap."
